Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.02
-0.01 (-0.09%)
Feb 21, 2025, 4:00 PM EST - Market closed
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $446.39 million as of February 21, 2025. Its market cap has decreased by -74.87% in one year.
Market Cap
446.39M
Enterprise Value
-65.01M
1-Year Change
-74.87%
Ranking
Category
Stock Price
$11.02
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $446.39M, an increase of 15.85%. That is a compound annual growth rate of 3.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 446.39M | -30.39% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 788.97B |
| UnitedHealth Group | 430.70B |
| Johnson & Johnson | 392.25B |
| Novo Nordisk | 370.84B |
| AbbVie | 359.45B |
| Abbott Laboratories | 234.06B |
| AstraZeneca | 229.50B |
| Merck & Co. | 225.11B |